EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors

Morteza Abdoli iD, Alessandro Bonardi iD, Claudiu T Supuran iD, Raivis Žalubovskis iD

Journal of Enzyme Inhibition and Medicinal Chemistry · 2023

DOI: 10.1080/14756366.2022.2152811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, 2023. Verfasst von Morteza Abdoli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A library of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates was synthesised by selective S-alkylation of the easily accessible 4-thioureidobenzenesulphonamide. The compounds were assayed as inhibitors of four human (h) carbonic anhydrase isoforms hCA I, II, VII, and XIII, as well as three bacterial enzymes belonging to the β-CA class, MscCA from Mammaliicoccus (Staphylococcus) sciuri and StCA1 and StCA2, from Salmonella enterica (serovar Typhimurium). Most compounds investigated here exhibited moderate to low nanomolar inhibition constants against hCA I, II, and VII. The cytosolic hCA XIII was also inhibited by these compounds, but not as effective as hCA I, II, and VII. Several compounds were very effective against MscCA and StCA1. StCA2 was less inhibited compared to MscCA and StCA1. Some compounds showed considerable selectivity for inhibiting some CA isoforms. They may thus be considered as interesting starting points for the discovery and development of novel therapeutic agents belonging to this class of enzyme inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsCarbonic AnhydrasesHumansCarbonic Anhydrase ICarbonic Anhydrase IIProtein IsoformsStructure-Activity RelationshipCarbonic Anhydrase IX

Stichwörter der Autor:innen

Carbonic anhydrasebacterial enzymescarbamimidothioatesinhibitorssulphonamides

Substanzen

Carbonic Anhydrase InhibitorsCarbonic AnhydrasesCarbonic Anhydrase ICarbonic Anhydrase IIProtein IsoformsCarbonic Anhydrase IX

Autor:innen und Institutionen

  • Institute of Technology of Organic Chemistry, Faculty of Materials Science and Applied Chemistry, Riga Technical University, Riga, Latvia.
  • Neurofarba Department, Universita Degli Studi di Firenze, Florence, Italy.
  • Latvian Institute of Organic Synthesis, Riga, Latvia.

ORCID-Profile: Morteza Abdoli, Alessandro Bonardi, Claudiu T Supuran, Raivis Žalubovskis

Förderung

  • European Union’s Horizon 2020

Zitieren

APA

Abdoli, M., Bonardi, A., Supuran, C. T., & Žalubovskis, R. (2023). Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. https://doi.org/10.1080/14756366.2022.2152811

Vancouver

Abdoli M, Bonardi A, Supuran CT, Žalubovskis R. Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 2023. doi:10.1080/14756366.2022.2152811

BibTeX
@article{Abdoli2023,
  author = {Abdoli, Morteza and Bonardi, Alessandro and Supuran, Claudiu T and Žalubovskis, Raivis},
  title = {Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2023},
  doi = {10.1080/14756366.2022.2152811}
}
Kostenlos starten →